Metrotonin | |
---|---|
Molecular structure via molpic based on CDK |
Conformer [] | |
---|---|
Physical properties [] | |
---|---|
Molecular mass | 163.26 g/mol [1] |
Predicted LogP | 2.7 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C11H17N [1] |
IUPAC name | N,N-dimethyl-1-phenylpropan-2-amine [1] |
SMILES | CC(CC1=CC=CC=C1)N(C)C [1] |
InChI | InChI=1S/C11H17N/c1-10(12(2)3)9-11-7-5-4-6-8-11/h4-8,10H,9H2,1-3H3 [1] |
InChIKey | OBDSVYOSYSKVMX-UHFFFAOYSA-N [1] |
Dimethylamphetamine
Dimethylamphetamine (also known as N,N-dimethylamphetamine, N,N,α-Trimethylphenethylamine, N,N,α-Trimethylbenzeneethanamine, Phenethylamine, n,n,α-trimethyl-, dimethyl(1-phenylpropan-2-yl)amine, J14.522J, N-methyl-methamphetamine, 1-Phenyl-2-dimethylaminopropane, 2-Dimethylamino-1-phenylpropane or 1-Phenyl-2-dimethylamino-propan) is a prodrug and stimulant substance of the amphetamine class.
Chemistry
Stereochemistry []
Dimethylamphetamine is a racemic mixture of the enantiomers
Stereoisomers |
---|
Pharmacology
Dimethylamphetamine acts as a prodrug for:
Active metabolites [] |
---|
Subjective effects
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 20006, Dimethylamphetamine. Accessed July 20, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/20006
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Dimethylamphetamine. UNII: IYE3F3MHCU. Global Substance Registration System. Accessed July 20, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/IYE3F3MHCU